Equillium, Inc.NASDAQ: EQ

Equillium to Participate in Upcoming Investor Conferences

· Issued by Equillium, Inc. via GlobeNewswire

Summary by 6ix AI

Equillium, Inc., a biotechnology company developing therapies for serious autoimmune and inflammatory disorders, said its management will participate in two investor conferences in November 2026.

Key details

  • Stifel 2026 Healthcare Conference: a fireside chat and one-on-one meetings on Thursday, November 12, 2026, at 9:20 AM EST.
  • 2026 Jefferies Global Healthcare Conference in London: one-on-one meetings from Tuesday, November 17 to Thursday, November 19, 2026.
  • Management will be available to meet with investors registered to attend each conference.

6ix AI wrote this summary from the release below and checked it against the release.

LA JOLLA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat serious autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:

Stifel 2026 Healthcare Conference
Format: Fireside Chat & 1x1 Meetings
Date: Thursday, November 12, 2026
Time: 9:20 AM EST

2026 Jefferies Global Healthcare Conference in London
Format: 1x1 Meetings
Date: Tuesday, November 17 – Thursday, November 19, 2026

Members of the Equillium management team will be available to meet with investors who are registered to attend each conference.

About Equillium
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat serious autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com.

Investor Contact 
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
[email protected]

View original source (GlobeNewswire)Equillium, Inc. on 6ix

Story so far

Earlier from Equillium

Later from Equillium

All Equillium news releases